Loading
A phase 3 trial of Bleomycin and Talc in Metastatic cancer, run by Eastern Cooperative Oncology Group, completed.
Bleomycin, Doxycycline, or Talc in Treating Patients With Malignant Pleural Effusions is a phase 3 interventional study registered as NCT00002872 by Eastern Cooperative Oncology Group, with 480 participants recorded, started 1997-01-10 and reaching its primary completion in 2003-02. Interventions recorded: bleomycin sulfate, doxycycline, talc. Conditions recorded: Metastatic Cancer.
Linked to the drug Talc because the registry names it among its interventions and Metastatic cancer among its conditions. Registry record only: no result has been read by an editor.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares Talc (intrapleural), Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Talc (intrapleural), Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Bleomycin and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/